comparemela.com

Latest Breaking News On - மருத்துவ சாரி - Page 6 : comparemela.com

Investegate |Faron Pharma Oy Announcements | Faron Pharma Oy: Holding(s) in Company

A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body; 4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;

U S Department of Defense (via Public) / General Officer Assignments

General Officer Assignments The secretary, U.S. Air Force, announces the following general officer assignments: Maj. Gen. Charles S. Corcoran will be assigned as assistant deputy chief of staff, operations, Headquarters U.S. Air Force, The Pentagon, Washington, D.C. Corcoran is currently serving as commander, U.S. Air Force Warfare Center, Air Combat Command, Nellis Air Force Base, Nevada. Maj. Gen. Case A. Cunningham will be assigned as commander, U.S. Air Force Warfare Center, Air Combat Command, Nellis Air Force Base, Nevada. Cunningham is currently serving as director, plans, programs, and requirements, Headquarters Air Combat Command, Joint Base Langley-Eustis, Virginia.

Investegate |Faron Pharma Oy Announcements | Faron Pharma Oy: Proposed Issue and Placing of Shares

  THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, SINGAPORE, HONG KONG OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.   THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE EU REGULATION 596/2014 ( MAR ) AND ARTICLE 7 OF MAR AS INCORPORATED INTO UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ( UK MAR ).   MEMBERS OF THE PUBLIC ARE NOT ELIGIBLE TO SUBSCRIBE FOR, OTHERWISE ACQUIRE OR DISPOSE OF ANY SECURITIES IN FARON PHARMACEUTICALS OY ( FARON ) PURSUANT TO THE PROPOSED TRANSACTION REFERRED TO IN THIS ANNOUNCEMENT. THIS ANNOUNCEMENT IS THEREFORE DIRECTED ONLY AT, IN A MEMBER STATE OF THE EUROPEAN ECONOMIC AREA, PERSONS WHO ARE QUALIFIED IN

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.